[go: up one dir, main page]

WO2005000099A3 - BLOOD FACTOR DOMAINS (BFDs) - Google Patents

BLOOD FACTOR DOMAINS (BFDs) Download PDF

Info

Publication number
WO2005000099A3
WO2005000099A3 PCT/US2004/018461 US2004018461W WO2005000099A3 WO 2005000099 A3 WO2005000099 A3 WO 2005000099A3 US 2004018461 W US2004018461 W US 2004018461W WO 2005000099 A3 WO2005000099 A3 WO 2005000099A3
Authority
WO
WIPO (PCT)
Prior art keywords
bfds
blood factor
factor domains
diseases
domains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2004/018461
Other languages
French (fr)
Other versions
WO2005000099A2 (en
Inventor
Bruce L Roberts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of WO2005000099A2 publication Critical patent/WO2005000099A2/en
Publication of WO2005000099A3 publication Critical patent/WO2005000099A3/en
Priority to US11/297,134 priority Critical patent/US20060111297A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The present invention provides methods and compositions for detecting, diagnosing, prognosing and monitoring the progress of diseases. Further provided are methods for screening to identify agonists and antagonists of antigens associated with these diseases.
PCT/US2004/018461 2003-06-09 2004-06-09 BLOOD FACTOR DOMAINS (BFDs) Ceased WO2005000099A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/297,134 US20060111297A1 (en) 2004-06-09 2005-12-08 Blood factor domains

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47729103P 2003-06-09 2003-06-09
US60/477,291 2003-06-09

Publications (2)

Publication Number Publication Date
WO2005000099A2 WO2005000099A2 (en) 2005-01-06
WO2005000099A3 true WO2005000099A3 (en) 2005-09-15

Family

ID=33551700

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/018461 Ceased WO2005000099A2 (en) 2003-06-09 2004-06-09 BLOOD FACTOR DOMAINS (BFDs)

Country Status (1)

Country Link
WO (1) WO2005000099A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007084388A2 (en) * 2006-01-12 2007-07-26 Sessa William C Nogo-b receptor
EP2533796A4 (en) * 2010-02-12 2013-12-04 Ngm Biopharmaceuticals Inc Methods of treating glucose metabolism disorders
WO2014165452A1 (en) * 2013-04-03 2014-10-09 The Regents Of The University Of California Compositions and methods for inhibiting viral activity
WO2016061286A2 (en) * 2014-10-14 2016-04-21 Halozyme, Inc. Compositions of adenosine deaminase-2 (ada2), variants thereof and methods of using same

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034626A1 (en) * 1999-11-05 2001-05-17 Human Genome Sciences, Inc. 28 human secreted proteins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034626A1 (en) * 1999-11-05 2001-05-17 Human Genome Sciences, Inc. 28 human secreted proteins

Also Published As

Publication number Publication date
WO2005000099A2 (en) 2005-01-06

Similar Documents

Publication Publication Date Title
WO2006020269A3 (en) Biomarkers of neurodegenerative disease
AU2002327308A1 (en) Methods for evaluating pathologic conditions using extracellular rna
WO2004112589A3 (en) Method for the detection of gene transcripts in blood and uses thereof
WO2004055519A3 (en) Specific markers for pancreatic cancer
WO2008105797A3 (en) Polynucleotides encoding novel pcsk9 variants
WO2011015944A3 (en) Use of free dna as an early predictor of severity in acute pancreatitis
WO2008063479A3 (en) Pancreatic cancer biomarkers
WO2005044990A3 (en) Use of differentially expressed nucleic acid sequences as biomarkers for cancer
WO2007114986A3 (en) Cooperative probes and methods of using them
WO2010041046A8 (en) Granin proteins as markers of heart disease
EP3284469A3 (en) Compositions and methods for detection of lysosomal storage disease
WO2006090389A3 (en) Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
WO2003048333A3 (en) Endorepellin compositions and methods for inhibiting angiogenesis
WO2006024466A3 (en) Test device for the in vitro diagnosis of multi-analyte tests and the use thereof
WO2007132120A3 (en) Procedure and methods for detecting alzheimer's disease
WO2007056523A3 (en) Methods for diagnosing and monitoring the progression of cancer
WO2006059252A3 (en) Methods and fluorinated compositions for treating amyloid-related diseases
WO2005085860A3 (en) New proliferation markers in clinical practice and their use for cancer prognosis or diagnosis
WO2006078911A3 (en) Gitr antibodies for the diagnosis of nsclc
WO2004045376A3 (en) Screening methods to identify treatments for autoimmune disease
WO2002080844A3 (en) Novel bgp compounds for therapy and diagnosis and methods for using same
WO2006085121A3 (en) Vgp peptide fragments as biomarkers for schizophrenic and bipolar disorders
WO2005000099A3 (en) BLOOD FACTOR DOMAINS (BFDs)
WO2003070902A3 (en) Receptors and membrane-associated proteins
WO2005124358A3 (en) Diagnosis and treatment of siglec-6 associated diseases

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 11297134

Country of ref document: US

122 Ep: pct application non-entry in european phase